Limited Submission Opportunities

Major Research Instrumentation Program (MRI)-Instrument Acquisition or Development- Solicitation. Internal selection process in progress, Letters of Interest due Nov 21, 2016

Upcoming Event:

“How CPRIT Supports Companies to Accelerate
the Progression of the Development of New Cancer Drugs, Diagnostics, and Therapies”

Presented by:

Mike Lang Mike Lang
Chief Product Development Research Officer

Thursday, December 8th,2016
AM to 10:00 AM

1000 Montgomery Fort Worth, TX
Medical Education and Training Building
MET-125S – South Auditorium



On December 8th, you can meet Mike Lang who will speak about how CPRIT has changed the face of research and innovation in Texas and how your company can benefit from partnering with CPRIT for funding to take your company to the next level. Mike will also share his experience on what constitutes the best “pitch” presentation to gain the attention of potential investors.
Texas voters overwhelmingly approved a constitutional amendment in 2007 establishing the Cancer Prevention and Research Institute of Texas (CPRIT) and authorizing the state to issue $3 billion in bonds to fund groundbreaking cancer research and prevention programs and services in Texas. CPRIT’s goal is to expedite innovation in cancer research and product development, and to enhance access to evidence-based prevention programs throughout the state. Under the guidance of its governing body, the Oversight Committee, CPRIT accepts applications and awards grants for a wide variety of cancer-related research and for the delivery of cancer prevention programs and services by public and private entities located in Texas. All CPRIT-funded research will be conducted in state by Texas-based scientists and reflect CPRIT’s mission to attract and expand the state’s research capabilities and create high quality new jobs in Texas.

Mr. Lang leads CPRIT’s product development research program, designed to accelerate the progression of new cancer drugs, diagnostics, and therapies from the laboratory into clinical practice. His multi-state experience includes founding and serving as chief executive officer of a cancer diagnostic company, serial entrepreneurship, and managing a portfolio for an early stage investment.Prior to joining CPRIT in November 2015, Mr. Lang was the founder and CEO of NanoVision, a cancer diagnostics company. He headed business development at the venture capital-funded wound healing company Gilatech, where he led its novel biomaterial therapy. Mr. Lang oversaw a company restructuring as president of Dallas-based Galt Medical, served as a product manager at Johnson & Johnson, and was vice president of business development at BioEnterprise, where he directed the startup and growth of early stage firms.Mr. Lang has a bachelor’s in biomedical engineering from Northern Arizona University and a master’s in business administration from Arizona State University.




NOTE: While the Office of Research Development & Commercialization makes every effort to list all limited submission programs on this website, and to allow the maximum allowed time of 60 days prior to sponsor deadline, programs may exist that are limited but not in our list to meet these deadlines. To maintain workable deadlines all faculty and staff should report any new program not listed on the website to for immediate communication to all researchers. If there is insufficient time for an internal competition to take place, an administrative decision may be made regarding which, if any, proposal(s) should be submitted.

Overall Process

  1. Announcement

Limited Submission opportunities will be announced by the Office of Research Development & Commercialization through the Limited Submissions Website, email and the Daily News. Information will include:

  • Name of sponsor and title of program
  • Internal deadline for submission of limited submission pre-proposals (no later than 60 days prior to sponsor deadline)
  • Sponsor deadline
  • Description of submission limitation
  • Link to program guidelines

Investigators are encouraged to contact the Office of Research Development to discuss their interest in a program. Please send information by email to

  1. Communication of Interest

A date is established for an email of intent to be sent to with copies to their Dean/Director, at least 60 days before the agency deadline. The subject line of the email should include the sponsor name and program title.  Investigators must be prepared to submit a pre-proposal if the number of participants exceed the allowable submissions.  If the number of submissions do not exceed the limitation, no internal competition will be required.

  1. Preparation of Pre-Proposal and Review by Limited Submission Committee

For each competition, principal investigators are required to submit a limited submission pre-proposal by the internal deadline specified in the announcement. The pre-proposal should address the sponsoring agency’s priorities as outlined in the announcement.

The pre-proposal should be no more than 3 pages in length in 11-point font with 0.5” margins and must contain the following information:

  • Proposal title
  • Principal Investigator and Co-Principal Investigator(s), Department and College
  • Proposed start date and duration of the project
  • Estimated (total) budget for the entire performance period
  • Summary of the project (main body of the document)

The pre-proposal should be sent as a PDF attachment to The subject line of the email should include the sponsor name and program title.

The limited submission committee will convene to review the pre-proposals following review guidelines. The committee will provide a recommendation to the Vice President of Research who makes the final decision regarding the internal competition.

  1. Notification of Decision to Internal Competitors

Once the VPR approves the nominee(s), the PI and their Dean/Director as well as the Office of Grants and Contracts Management will be notified by email by the Office of Research Development & Commercialization. PI’s whose projects were not selected will be notified as well.

  1. Submission of Final Proposal to Sponsor

The PI selected to apply for a limited submission opportunity has the responsibility to submit the application in a timely manner.

Should the candidate wish to decline the nomination, they need to do so in writing within 5 business days of selection notification to

This page was last modified on November 15, 2016